Markus Peck‐Radosavljevic

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib

Andrew X. Zhu, Masatoshi Kudo, Eric Assénat et al. · JAMA · 2014 · 564 citations · Full text

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Michael P. Manns, Didier Samuel, Edward Gane et al. · The Lancet Infectious Diseases · 2016 · 442 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +7

Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation

Guobin He, Guann‐Yi Yu, Vladislav Temkin et al. · Cancer Cell · 2010 · 425 citations · Full text

Inflammation, Cancer Research, Reductive Stress +11